<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_medium=rss&amp;ff=20240430001142&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_medium=rss&amp;ff=20240430001142&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 30 Apr 2024 04:11:44 +0000</lastbuilddate>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Unraveling the Unsolved Mysteries of the Athletic Heart</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38683901/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 30;149(18):1416-1418. doi: 10.1161/CIRCULATIONAHA.124.064534. Epub 2024 Apr 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38683901/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38683901</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.064534>10.1161/CIRCULATIONAHA.124.064534</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38683901</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>William K Cornwell</dc:creator>
<dc:creator>Benjamin D Levine</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Unraveling the Unsolved Mysteries of the Athletic Heart</dc:title>
<dc:identifier>pmid:38683901</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.064534</dc:identifier>
</item>
<item>
<title>Empowering Valvular Heart Disease Research With Stem Cell-Derived Valve Cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38683900/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 30;149(18):1457-1460. doi: 10.1161/CIRCULATIONAHA.124.068656. Epub 2024 Apr 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38683900/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38683900</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068656>10.1161/CIRCULATIONAHA.124.068656</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38683900</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Mengcheng Shen</dc:creator>
<dc:creator>Joseph C Wu</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Empowering Valvular Heart Disease Research With Stem Cell-Derived Valve Cells</dc:title>
<dc:identifier>pmid:38683900</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068656</dc:identifier>
</item>
<item>
<title>Global Rounds: Cardiovascular Care in Australia and New Zealand</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38683899/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 30;149(18):1402-1404. doi: 10.1161/CIRCULATIONAHA.123.064271. Epub 2024 Apr 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38683899/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38683899</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064271>10.1161/CIRCULATIONAHA.123.064271</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38683899</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Sarah Zaman</dc:creator>
<dc:creator>Nicola C Edwards</dc:creator>
<dc:creator>Derek P Chew</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Global Rounds: Cardiovascular Care in Australia and New Zealand</dc:title>
<dc:identifier>pmid:38683899</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064271</dc:identifier>
</item>
<item>
<title>Peripheral Oxygenation and Pulmonary Hemodynamics in Individuals With Fontan Circulation During 24-Hour High-Altitude Exposure Simulation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38683898/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 30;149(18):1466-1468. doi: 10.1161/CIRCULATIONAHA.123.067601. Epub 2024 Apr 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38683898/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38683898</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067601>10.1161/CIRCULATIONAHA.123.067601</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38683898</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Nicole Müller</dc:creator>
<dc:creator>Julian Alexander Härtel</dc:creator>
<dc:creator>Jan Schmitz</dc:creator>
<dc:creator>Ute Baur</dc:creator>
<dc:creator>Melanie von der Wiesche</dc:creator>
<dc:creator>Iris Rieger</dc:creator>
<dc:creator>Darius Gerlach</dc:creator>
<dc:creator>Jon von Stritzky</dc:creator>
<dc:creator>Anja Bach</dc:creator>
<dc:creator>Christopher Hart</dc:creator>
<dc:creator>Janina Bros</dc:creator>
<dc:creator>Benedikt Seeger</dc:creator>
<dc:creator>Emily Zollmann</dc:creator>
<dc:creator>Marijke Grau</dc:creator>
<dc:creator>Boris Dragutinovic</dc:creator>
<dc:creator>Laura-Maria de Boni</dc:creator>
<dc:creator>Jan-Niklas Hönemann</dc:creator>
<dc:creator>Wilhelm Bloch</dc:creator>
<dc:creator>Daniel Aeschbach</dc:creator>
<dc:creator>Eva-Maria Elmenhorst</dc:creator>
<dc:creator>Ulrike Herberg</dc:creator>
<dc:creator>Alena Hess</dc:creator>
<dc:creator>Moritz Schumann</dc:creator>
<dc:creator>Tobias Kratz</dc:creator>
<dc:creator>Jens Jordan</dc:creator>
<dc:creator>Johannes Breuer</dc:creator>
<dc:creator>Jens Tank</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Peripheral Oxygenation and Pulmonary Hemodynamics in Individuals With Fontan Circulation During 24-Hour High-Altitude Exposure Simulation</dc:title>
<dc:identifier>pmid:38683898</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067601</dc:identifier>
</item>
<item>
<title>Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38683897/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 30;149(18):e1133. doi: 10.1161/CIRCULATIONAHA.124.068825. Epub 2024 Apr 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38683897/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38683897</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068825>10.1161/CIRCULATIONAHA.124.068825</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38683897</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Matthew Kelham</dc:creator>
<dc:creator>Anthony Mathur</dc:creator>
<dc:creator>Daniel A Jones</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial"</dc:title>
<dc:identifier>pmid:38683897</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068825</dc:identifier>
</item>
<item>
<title>Adult Congenital Heart Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38683896/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 30;149(18):1397-1399. doi: 10.1161/CIRCULATIONAHA.123.066983. Epub 2024 Apr 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38683896/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38683896</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066983>10.1161/CIRCULATIONAHA.123.066983</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38683896</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Mikael Dellborg</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Adult Congenital Heart Disease</dc:title>
<dc:identifier>pmid:38683896</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066983</dc:identifier>
</item>
<item>
<title>Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38683895/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 30;149(18):e1132. doi: 10.1161/CIRCULATIONAHA.123.067850. Epub 2024 Apr 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38683895/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38683895</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067850>10.1161/CIRCULATIONAHA.123.067850</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38683895</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Anastasios Apostolos</dc:creator>
<dc:creator>Grigoris V Karamasis</dc:creator>
<dc:creator>Grigorios Tsigkas</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial"</dc:title>
<dc:identifier>pmid:38683895</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067850</dc:identifier>
</item>
<item>
<title>Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38683894/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 30;149(18):1400-1401. doi: 10.1161/CIRCULATIONAHA.123.065904. Epub 2024 Apr 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38683894/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38683894</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065904>10.1161/CIRCULATIONAHA.123.065904</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38683894</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Caren G Solomon</dc:creator>
<dc:creator>Philip J Landrigan</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action</dc:title>
<dc:identifier>pmid:38683894</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065904</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38683893/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 30;149(18):1461-1465. doi: 10.1161/CIRCULATIONAHA.124.069841. Epub 2024 Apr 29.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38683893/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38683893</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069841>10.1161/CIRCULATIONAHA.124.069841</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38683893</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:38683893</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069841</dc:identifier>
</item>
<item>
<title>ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38682338/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These results are the first to establish that a single prospective marker identifies CRECs in mice and human individuals, which holds promise to provide new cell therapies for repair of damaged vessels in patients with endothelial dysfunction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.122.061833. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Most organs are maintained lifelong by resident stem/progenitor cells. During development and regeneration, lineage-specific stem/progenitor cells can contribute to the growth or maintenance of different organs, whereas fully differentiated mature cells have less regenerative potential. However, it is unclear whether vascular endothelial cells (ECs) are also replenished by stem/progenitor cells with EC-repopulating potential residing in blood vessels. It has been reported recently that some EC populations possess higher clonal proliferative potential and vessel-forming capacity compared with mature ECs. Nevertheless, a marker to identify vascular clonal repopulating ECs (CRECs) in murine and human individuals is lacking, and, hence, the mechanism for the proliferative, self-renewal, and vessel-forming potential of CRECs is elusive.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We analyzed colony-forming, self-renewal, and vessel-forming potential of ABCG2 (ATP binding cassette subfamily G member 2)-expressing ECs in human umbilical vessels. To study the contribution of <i>Abcg2</i>-expressing ECs to vessel development and regeneration, we developed Abcg2Cre<sup>Ert2</sup>;ROSA TdTomato mice and performed lineage tracing during mouse development and during tissue regeneration after myocardial infarction injury. RNA sequencing and chromatin methylation chromatin immunoprecipitation followed by sequencing were conducted to study the gene regulation in <i>Abcg2</i>-expressing ECs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In human and mouse vessels, ECs with higher <i>ABCG2</i> expression (ABCECs) possess higher clonal proliferative potential and in vivo vessel-forming potential compared with mature ECs. These cells could clonally contribute to vessel formation in primary and secondary recipients after transplantation. These features of ABCECs meet the criteria of CRECs. Results from lineage tracing experiments confirm that <i>Abcg2</i>-expressing CRECs (<i>Abc</i>CRECs) contribute to arteries, veins, and capillaries in cardiac tissue development and vascular tissue regeneration after myocardial infarction. Transcriptome and epigenetic analyses reveal that a gene expression signature involved in angiogenesis and vessel development is enriched in <i>Abc</i>CRECs. In addition, various angiogenic genes, such as <i>Notch2</i> and <i>Hey2</i>, are bivalently modified by trimethylation at the 4th and 27th lysine residue of histone H3 (H3K4me3 and H3K27me3) in <i>Abc</i>CRECs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These results are the first to establish that a single prospective marker identifies CRECs in mice and human individuals, which holds promise to provide new cell therapies for repair of damaged vessels in patients with endothelial dysfunction.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38682338/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38682338</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.122.061833>10.1161/CIRCULATIONAHA.122.061833</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38682338</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Yang Lin</dc:creator>
<dc:creator>Chang-Hyun Gil</dc:creator>
<dc:creator>Kimihiko Banno</dc:creator>
<dc:creator>Masataka Yokoyama</dc:creator>
<dc:creator>Matthew Wingo</dc:creator>
<dc:creator>Ellen Go</dc:creator>
<dc:creator>Nutan Prasain</dc:creator>
<dc:creator>Ying Liu</dc:creator>
<dc:creator>Takashi Hato</dc:creator>
<dc:creator>Hisamichi Naito</dc:creator>
<dc:creator>Taku Wakabayashi</dc:creator>
<dc:creator>Musia Sominskaia</dc:creator>
<dc:creator>Meng Gao</dc:creator>
<dc:creator>Kevin Chen</dc:creator>
<dc:creator>Fuqiang Geng</dc:creator>
<dc:creator>Jesus Maria Gomez Salinero</dc:creator>
<dc:creator>Sisi Chen</dc:creator>
<dc:creator>W Christopher Shelley</dc:creator>
<dc:creator>Momoko Yoshimoto</dc:creator>
<dc:creator>Sergio Li Calzi</dc:creator>
<dc:creator>Michael P Murphy</dc:creator>
<dc:creator>Kyoji Horie</dc:creator>
<dc:creator>Maria B Grant</dc:creator>
<dc:creator>Ryan Schreiner</dc:creator>
<dc:creator>David Redmond</dc:creator>
<dc:creator>David P Basile</dc:creator>
<dc:creator>Shahin Rafii</dc:creator>
<dc:creator>Mervin C Yoder</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels</dc:title>
<dc:identifier>pmid:38682338</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.122.061833</dc:identifier>
</item>
<item>
<title>CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38682330/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our study identifies unbridled turnover of the potassium channel hERG as a mechanism supporting the interindividual susceptibility underlying diLQT development and demonstrates how this phenomenon is finely tuned by CAVIN1.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.123.063917. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Drug-induced QT prolongation (diLQT) is a feared side effect that could expose susceptible individuals to fatal arrhythmias. The occurrence of diLQT is primarily attributed to unintended drug interactions with cardiac ion channels, notably the hERG (human ether-a-go-go-related gene) channels that generate the delayed-rectifier potassium current (I<sub>Kr</sub>) and thereby regulate the late repolarization phase. There is an important interindividual susceptibility to develop diLQT, which is of unknown origin but can be reproduced in patient-specific induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs). We aimed to investigate the dynamics of hERG channels in response to sotalol and to identify regulators of the susceptibility to developing diLQT.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We measured electrophysiological activity and cellular distribution of hERG channels after hERG blocker treatment in iPS-CMs derived from patients with highest sensitivity (HS) or lowest sensitivity (LS) to sotalol administration in vivo (ie, on the basis of the measure of the maximal change in QT interval 3 hours after administration). Specific small interfering RNAs and CAVIN1-T2A-GFP adenovirus were used to manipulate <i>CAVIN1</i> expression.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Whereas HS and LS iPS-CMs showed similar electrophysiological characteristics at baseline, the late repolarization phase was prolonged and I<sub>Kr</sub> significantly decreased after exposure of HS iPS-CMs to low sotalol concentrations. I<sub>Kr</sub> reduction was caused by a rapid translocation of hERG channel from the membrane to the cytoskeleton-associated fractions upon sotalol application. <i>CAVIN1</i>, essential for caveolae biogenesis, was 2× more highly expressed in HS iPS-CMs, and its knockdown by small interfering RNA reduced their sensitivity to sotalol. <i>CAVIN1</i> overexpression in LS iPS-CMs using adenovirus showed reciprocal effects. We found that treatment with sotalol promoted translocation of the hERG channel from the plasma membrane to the cytoskeleton fractions in a process dependent on CAVIN1 (caveolae associated protein 1) expression. <i>CAVIN1</i> silencing reduced the number of caveolae at the membrane and abrogated the translocation of hERG channel in sotalol-treated HS iPS-CMs. CAVIN1 also controlled cardiomyocyte responses to other hERG blockers, such as E4031, vandetanib, and clarithromycin.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our study identifies unbridled turnover of the potassium channel hERG as a mechanism supporting the interindividual susceptibility underlying diLQT development and demonstrates how this phenomenon is finely tuned by CAVIN1.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38682330/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38682330</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.063917>10.1161/CIRCULATIONAHA.123.063917</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38682330</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Zeina R Al Sayed</dc:creator>
<dc:creator>Céline Pereira</dc:creator>
<dc:creator>Rémi Le Borgne</dc:creator>
<dc:creator>Christine Viaris de Lesegno</dc:creator>
<dc:creator>Charlène Jouve</dc:creator>
<dc:creator>Esthel Pénard</dc:creator>
<dc:creator>Adeline Mallet</dc:creator>
<dc:creator>Nihar Masurkar</dc:creator>
<dc:creator>Gildas Loussouarn</dc:creator>
<dc:creator>Jean-Marc Verbavatz</dc:creator>
<dc:creator>Christophe Lamaze</dc:creator>
<dc:creator>David-Alexandre Trégouët</dc:creator>
<dc:creator>Jean-Sébastien Hulot</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT</dc:title>
<dc:identifier>pmid:38682330</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.063917</dc:identifier>
</item>
<item>
<title>PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38682326/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: PBK is a newly described target for PAH that is upregulated in proliferating PA smooth muscle cells, where it contributes to proliferation through changes in cytokinesis and cell cycle dynamics to promote medial thickening, fibrosis, increased PA resistance, elevated right ventricular systolic pressure, right ventricular remodeling, and PH.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.123.067095. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Pulmonary arterial hypertension (PAH) is high blood pressure in the lungs that originates from structural changes in small resistance arteries. A defining feature of PAH is the inappropriate remodeling of pulmonary arteries (PA) leading to right ventricle failure and death. Although treatment of PAH has improved, the long-term prognosis for patients remains poor, and more effective targets are needed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Gene expression was analyzed by microarray, RNA sequencing, quantitative polymerase chain reaction, Western blotting, and immunostaining of lung and isolated PA in multiple mouse and rat models of pulmonary hypertension (PH) and human PAH. PH was assessed by digital ultrasound, hemodynamic measurements, and morphometry.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Microarray analysis of the transcriptome of hypertensive rat PA identified a novel candidate, PBK (PDZ-binding kinase), that was upregulated in multiple models and species including humans. PBK is a serine/threonine kinase with important roles in cell proliferation that is minimally expressed in normal tissues but significantly increased in highly proliferative tissues. PBK was robustly upregulated in the medial layer of PA, where it overlaps with markers of smooth muscle cells. Gain-of-function approaches show that active forms of PBK increase PA smooth muscle cell proliferation, whereas silencing PBK, dominant negative PBK, and pharmacological inhibitors of PBK all reduce proliferation. Pharmacological inhibitors of PBK were effective in PH reversal strategies in both mouse and rat models, providing translational significance. In a complementary genetic approach, PBK was knocked out in rats using CRISPR/Cas9 editing, and loss of PBK prevented the development of PH. We found that PBK bound to PRC1 (protein regulator of cytokinesis 1) in PA smooth muscle cells and that multiple genes involved in cytokinesis were upregulated in experimental models of PH and human PAH. Active PBK increased PRC1 phosphorylation and supported cytokinesis in PA smooth muscle cells, whereas silencing or dominant negative PBK reduced cytokinesis and the number of cells in the G2/M phase of the cell cycle.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: PBK is a newly described target for PAH that is upregulated in proliferating PA smooth muscle cells, where it contributes to proliferation through changes in cytokinesis and cell cycle dynamics to promote medial thickening, fibrosis, increased PA resistance, elevated right ventricular systolic pressure, right ventricular remodeling, and PH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38682326/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38682326</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067095>10.1161/CIRCULATIONAHA.123.067095</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38682326</guid>
<pubDate>Mon, 29 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Zsuzsanna Bordan</dc:creator>
<dc:creator>Robert Batori</dc:creator>
<dc:creator>Stephen Haigh</dc:creator>
<dc:creator>Xueyi Li</dc:creator>
<dc:creator>Mary Louise Meadows</dc:creator>
<dc:creator>Zach L Brown</dc:creator>
<dc:creator>Madison A West</dc:creator>
<dc:creator>Kunzhe Dong</dc:creator>
<dc:creator>Weihong Han</dc:creator>
<dc:creator>Yunchao Su</dc:creator>
<dc:creator>Qian Ma</dc:creator>
<dc:creator>Yuqing Huo</dc:creator>
<dc:creator>Jiliang Zhou</dc:creator>
<dc:creator>Mahmoud Abdelbary</dc:creator>
<dc:creator>Jennifer Sullivan</dc:creator>
<dc:creator>Neal L Weintraub</dc:creator>
<dc:creator>David W Stepp</dc:creator>
<dc:creator>Feng Chen</dc:creator>
<dc:creator>Scott A Barman</dc:creator>
<dc:creator>David J R Fulton</dc:creator>
<dc:date>2024-04-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension</dc:title>
<dc:identifier>pmid:38682326</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067095</dc:identifier>
</item>
<item>
<title>Long-term outcomes after hospitalization for atrial fibrillation or flutter</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38678737/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Patients hospitalized for AF or flutter had high death rates with an average 2.6-year loss in life expectancy. Moreover, re-hospitalizations for AF or flutter and related outcomes such as heart failure and stroke were common with catheter ablation used infrequently for treatment, which warrant further actions.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093/eurheartj/ehae204. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Atrial fibrillation (AF) and flutter are common causes of hospitalizations but contemporary long-term outcomes following these episodes are uncertain. This study assessed outcomes up to 10 years after an acute AF or flutter hospitalization.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Patients hospitalized acutely with a primary diagnosis of AF or flutter from 2008-17 from all public and most private hospitals in Australia and New Zealand were included. Kaplan-Meier methods and flexible parametric survival modelling were used to estimate survival and loss in life expectancy, respectively. Competing risk model accounting for death was used when estimating incidence of non-fatal outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 260 492 adults (mean age 70.5 ± 14.4 years, 49.6% female) were followed up for 1 068 009 person-years (PY), during which 69 167 died (incidence rate 6.5/100 PY) with 91.2% survival at 1 year, 72.7% at 5 years, and 55.2% at 10 years. Estimated loss in life expectancy was 2.6 years, or 16.8% of expected life expectancy. Re-hospitalizations for heart failure (2.9/100 PY), stroke (1.7/100 PY), and myocardial infarction (1.1/100 PY) were common with respective cumulative incidences of 16.8%, 11.0%, and 7.1% by 10 years. Re-hospitalization for AF or flutter occurred in 21.3% by 1 year, 35.3% by 5 years, and 41.2% by 10 years (11.6/100 PY). The cumulative incidence of patients undergoing catheter ablation of AF was 6.5% at 10 years (1.2/100 PY).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Patients hospitalized for AF or flutter had high death rates with an average 2.6-year loss in life expectancy. Moreover, re-hospitalizations for AF or flutter and related outcomes such as heart failure and stroke were common with catheter ablation used infrequently for treatment, which warrant further actions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38678737/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38678737</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae204>10.1093/eurheartj/ehae204</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38678737</guid>
<pubDate>Sun, 28 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Linh Thi Hai Ngo</dc:creator>
<dc:creator>Yang Peng</dc:creator>
<dc:creator>Russell Denman</dc:creator>
<dc:creator>Ian Yang</dc:creator>
<dc:creator>Isuru Ranasinghe</dc:creator>
<dc:date>2024-04-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Long-term outcomes after hospitalization for atrial fibrillation or flutter</dc:title>
<dc:identifier>pmid:38678737</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae204</dc:identifier>
</item>
<item>
<title>Where are cardiology's nuts and bolts to be found?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38676374/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 27:ehae209. doi: 10.1093/eurheartj/ehae209. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38676374/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38676374</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae209>10.1093/eurheartj/ehae209</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38676374</guid>
<pubDate>Sat, 27 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Peter Lanzer</dc:creator>
<dc:date>2024-04-27</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Where are cardiology's nuts and bolts to be found?</dc:title>
<dc:identifier>pmid:38676374</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae209</dc:identifier>
</item>
<item>
<title>Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670073/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>Nuclear factor κB (NF-κB) plays roles in various diseases. Many inflammatory signals, such as circulating lipopolysaccharides (LPSs), activate NF-κB via specific receptors. Using whole-genome CRISPR-Cas9 screens of LPS-treated cells that express an NF-κB-driven suicide gene, we discovered that the LPS receptor Toll-like receptor 4 (TLR4) is specifically dependent on the oligosaccharyltransferase complex OST-A for N-glycosylation and cell-surface localization. The tool compound NGI-1 inhibits OST...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2209-2223.e16. doi: 10.1016/j.cell.2024.03.022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Nuclear factor κB (NF-κB) plays roles in various diseases. Many inflammatory signals, such as circulating lipopolysaccharides (LPSs), activate NF-κB via specific receptors. Using whole-genome CRISPR-Cas9 screens of LPS-treated cells that express an NF-κB-driven suicide gene, we discovered that the LPS receptor Toll-like receptor 4 (TLR4) is specifically dependent on the oligosaccharyltransferase complex OST-A for N-glycosylation and cell-surface localization. The tool compound NGI-1 inhibits OST complexes in vivo, but the underlying molecular mechanism remained unknown. We did a CRISPR base-editor screen for NGI-1-resistant variants of STT3A, the catalytic subunit of OST-A. These variants, in conjunction with cryoelectron microscopy studies, revealed that NGI-1 binds the catalytic site of STT3A, where it traps a molecule of the donor substrate dolichyl-PP-GlcNAc<sub>2</sub>-Man<sub>9</sub>-Glc<sub>3</sub>, suggesting an uncompetitive inhibition mechanism. Our results provide a rationale for and an initial step toward the development of STT3A-specific inhibitors and illustrate the power of contemporaneous base-editor and structural studies to define drug mechanism of action.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670073/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38670073</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.022>10.1016/j.cell.2024.03.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670073</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Benjamin L Lampson</dc:creator>
<dc:creator>Ana S Ramίrez</dc:creator>
<dc:creator>Marta Baro</dc:creator>
<dc:creator>Lixia He</dc:creator>
<dc:creator>Mudra Hegde</dc:creator>
<dc:creator>Vidyasagar Koduri</dc:creator>
<dc:creator>Jamie L Pfaff</dc:creator>
<dc:creator>Ruth E Hanna</dc:creator>
<dc:creator>Julia Kowal</dc:creator>
<dc:creator>Nitin H Shirole</dc:creator>
<dc:creator>Yanfeng He</dc:creator>
<dc:creator>John G Doench</dc:creator>
<dc:creator>Joseph N Contessa</dc:creator>
<dc:creator>Kaspar P Locher</dc:creator>
<dc:creator>William G Kaelin</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB</dc:title>
<dc:identifier>pmid:38670073</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.022</dc:identifier>
</item>
<item>
<title>Functional sensory circuits built from neurons of two species</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670072/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>A central question for regenerative neuroscience is whether synthetic neural circuits, such as those built from two species, can function in an intact brain. Here, we apply blastocyst complementation to selectively build and test interspecies neural circuits. Despite approximately 10-20 million years of evolution, and prominent species differences in brain size, rat pluripotent stem cells injected into mouse blastocysts develop and persist throughout the mouse brain. Unexpectedly, the mouse...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2143-2157.e15. doi: 10.1016/j.cell.2024.03.042.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A central question for regenerative neuroscience is whether synthetic neural circuits, such as those built from two species, can function in an intact brain. Here, we apply blastocyst complementation to selectively build and test interspecies neural circuits. Despite approximately 10-20 million years of evolution, and prominent species differences in brain size, rat pluripotent stem cells injected into mouse blastocysts develop and persist throughout the mouse brain. Unexpectedly, the mouse niche reprograms the birth dates of rat neurons in the cortex and hippocampus, supporting rat-mouse synaptic activity. When mouse olfactory neurons are genetically silenced or killed, rat neurons restore information flow to odor processing circuits. Moreover, they rescue the primal behavior of food seeking, although less well than mouse neurons. By revealing that a mouse can sense the world using neurons from another species, we establish neural blastocyst complementation as a powerful tool to identify conserved mechanisms of brain development, plasticity, and repair.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670072/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38670072</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.042>10.1016/j.cell.2024.03.042</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670072</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Benjamin T Throesch</dc:creator>
<dc:creator>Muhammad Khadeesh Bin Imtiaz</dc:creator>
<dc:creator>Rodrigo Muñoz-Castañeda</dc:creator>
<dc:creator>Masahiro Sakurai</dc:creator>
<dc:creator>Andrea L Hartzell</dc:creator>
<dc:creator>Kiely N James</dc:creator>
<dc:creator>Alberto R Rodriguez</dc:creator>
<dc:creator>Greg Martin</dc:creator>
<dc:creator>Giordano Lippi</dc:creator>
<dc:creator>Sergey Kupriyanov</dc:creator>
<dc:creator>Zhuhao Wu</dc:creator>
<dc:creator>Pavel Osten</dc:creator>
<dc:creator>Juan Carlos Izpisua Belmonte</dc:creator>
<dc:creator>Jun Wu</dc:creator>
<dc:creator>Kristin K Baldwin</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Functional sensory circuits built from neurons of two species</dc:title>
<dc:identifier>pmid:38670072</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.042</dc:identifier>
</item>
<item>
<title>Generation of rat forebrain tissues in mice</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670071/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>Interspecies blastocyst complementation (IBC) provides a unique platform to study development and holds the potential to overcome worldwide organ shortages. Despite recent successes, brain tissue has not been achieved through IBC. Here, we developed an optimized IBC strategy based on C-CRISPR, which facilitated rapid screening of candidate genes and identified that Hesx1 deficiency supported the generation of rat forebrain tissue in mice via IBC. Xenogeneic rat forebrain tissues in adult mice...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2129-2142.e17. doi: 10.1016/j.cell.2024.03.017.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Interspecies blastocyst complementation (IBC) provides a unique platform to study development and holds the potential to overcome worldwide organ shortages. Despite recent successes, brain tissue has not been achieved through IBC. Here, we developed an optimized IBC strategy based on C-CRISPR, which facilitated rapid screening of candidate genes and identified that Hesx1 deficiency supported the generation of rat forebrain tissue in mice via IBC. Xenogeneic rat forebrain tissues in adult mice were structurally and functionally intact. Cross-species comparative analyses revealed that rat forebrain tissues developed at the same pace as the mouse host but maintained rat-like transcriptome profiles. The chimeric rate of rat cells gradually decreased as development progressed, suggesting xenogeneic barriers during mid-to-late pre-natal development. Interspecies forebrain complementation opens the door for studying evolutionarily conserved and divergent mechanisms underlying brain development and cognitive function. The C-CRISPR-based IBC strategy holds great potential to broaden the study and application of interspecies organogenesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670071/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38670071</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.017>10.1016/j.cell.2024.03.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670071</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jia Huang</dc:creator>
<dc:creator>Bingbing He</dc:creator>
<dc:creator>Xiali Yang</dc:creator>
<dc:creator>Xin Long</dc:creator>
<dc:creator>Yinghui Wei</dc:creator>
<dc:creator>Leijie Li</dc:creator>
<dc:creator>Min Tang</dc:creator>
<dc:creator>Yanxia Gao</dc:creator>
<dc:creator>Yuan Fang</dc:creator>
<dc:creator>Wenqin Ying</dc:creator>
<dc:creator>Zikang Wang</dc:creator>
<dc:creator>Chao Li</dc:creator>
<dc:creator>Yingsi Zhou</dc:creator>
<dc:creator>Shuaishuai Li</dc:creator>
<dc:creator>Linyu Shi</dc:creator>
<dc:creator>Seungwon Choi</dc:creator>
<dc:creator>Haibo Zhou</dc:creator>
<dc:creator>Fan Guo</dc:creator>
<dc:creator>Hui Yang</dc:creator>
<dc:creator>Jun Wu</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Generation of rat forebrain tissues in mice</dc:title>
<dc:identifier>pmid:38670071</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.017</dc:identifier>
</item>
<item>
<title>Mapping the pancancer metastasis tumor microbiome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670070/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>The landscape of the intratumoral microbiome in tumor metastases is largely unchartered. In this issue of Cell, Voest et al. profiled the tumor metastasis-associated microbiome in a pancancer cohort of 4,160 biopsies from 26 cancer types. This dataset offers a useful resource for understanding the role of the microbiome in metastatic cancers.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2126-2128. doi: 10.1016/j.cell.2024.03.040.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The landscape of the intratumoral microbiome in tumor metastases is largely unchartered. In this issue of Cell, Voest et al. profiled the tumor metastasis-associated microbiome in a pancancer cohort of 4,160 biopsies from 26 cancer types. This dataset offers a useful resource for understanding the role of the microbiome in metastatic cancers.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670070/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38670070</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.040>10.1016/j.cell.2024.03.040</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670070</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Chi Chun Wong</dc:creator>
<dc:creator>Jun Yu</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Mapping the pancancer metastasis tumor microbiome</dc:title>
<dc:identifier>pmid:38670070</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.040</dc:identifier>
</item>
<item>
<title>A glycolytic metabolite that drives BRCA2 haploinsufficiency</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670069/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>Many types of tumor cells alter metabolic pathways to meet their energy and biosynthetic demands for proliferation or stress adaptation. In this issue of Cell, Kong et al. find that the glycolytic metabolite methylglyoxal causes cancer-associated mutant single-base substitution features by inducing BRCA2 proteolysis, leading to functional haploinsufficiency of BRCA2.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2124-2126. doi: 10.1016/j.cell.2024.03.028.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Many types of tumor cells alter metabolic pathways to meet their energy and biosynthetic demands for proliferation or stress adaptation. In this issue of Cell, Kong et al. find that the glycolytic metabolite methylglyoxal causes cancer-associated mutant single-base substitution features by inducing BRCA2 proteolysis, leading to functional haploinsufficiency of BRCA2.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670069/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38670069</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.028>10.1016/j.cell.2024.03.028</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670069</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Peng Jiang</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A glycolytic metabolite that drives BRCA2 haploinsufficiency</dc:title>
<dc:identifier>pmid:38670069</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.028</dc:identifier>
</item>
<item>
<title>Many paths lead to immunology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670068/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>While some people pore over the textbook and train through the classics of the field, many scientists come to immunology when they discover it intersecting with their "first love" interests. Five of these "accidental immunologists" tell us how they found their way to a fascination with the immune system.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2117-2119. doi: 10.1016/j.cell.2024.03.033.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">While some people pore over the textbook and train through the classics of the field, many scientists come to immunology when they discover it intersecting with their "first love" interests. Five of these "accidental immunologists" tell us how they found their way to a fascination with the immune system.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670068/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38670068</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.033>10.1016/j.cell.2024.03.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670068</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Ana J García-Sáez</dc:creator>
<dc:creator>Ana I Domingos</dc:creator>
<dc:creator>J Silvio Gutkind</dc:creator>
<dc:creator>Seema Mattoo</dc:creator>
<dc:creator>Peng Du</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Many paths lead to immunology</dc:title>
<dc:identifier>pmid:38670068</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.033</dc:identifier>
</item>
<item>
<title>The plant immune system: From discovery to deployment</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38670067/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240430001142&amp;v=2.18.0.post9+e462414
      <description>Plant diseases cause famines, drive human migration, and present challenges to agricultural sustainability as pathogen ranges shift under climate change. Plant breeders discovered Mendelian genetic loci conferring disease resistance to specific pathogen isolates over 100 years ago. Subsequent breeding for disease resistance underpins modern agriculture and, along with the emergence and focus on model plants for genetics and genomics research, has provided rich resources for molecular biological...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 25;187(9):2095-2116. doi: 10.1016/j.cell.2024.03.045.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Plant diseases cause famines, drive human migration, and present challenges to agricultural sustainability as pathogen ranges shift under climate change. Plant breeders discovered Mendelian genetic loci conferring disease resistance to specific pathogen isolates over 100 years ago. Subsequent breeding for disease resistance underpins modern agriculture and, along with the emergence and focus on model plants for genetics and genomics research, has provided rich resources for molecular biological exploration over the last 50 years. These studies led to the identification of extracellular and intracellular receptors that convert recognition of extracellular microbe-encoded molecular patterns or intracellular pathogen-delivered virulence effectors into defense activation. These receptor systems, and downstream responses, define plant immune systems that have evolved since the migration of plants to land ∼500 million years ago. Our current understanding of plant immune systems provides the platform for development of rational resistance enhancement to control the many diseases that continue to plague crop production.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38670067/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240430001142&v=2.18.0.post9+e462414">38670067</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.045>10.1016/j.cell.2024.03.045</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38670067</guid>
<pubDate>Fri, 26 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jonathan D G Jones</dc:creator>
<dc:creator>Brian J Staskawicz</dc:creator>
<dc:creator>Jeffery L Dangl</dc:creator>
<dc:date>2024-04-26</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The plant immune system: From discovery to deployment</dc:title>
<dc:identifier>pmid:38670067</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.045</dc:identifier>
</item>





























</channel>
</rss>